Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etripamil Nasal Spray for PSVT (NODE-301/RAPID)
NCT03464019Phase 3Terminated
- Sponsor
- Milestone Pharmaceuticals
- Start
- Jun 2018
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of etripamil in paroxysmal supraventricular tachycardia (PSVT), sponsored by Milestone Pharmaceuticals. Started Jun 2018; status: terminated.
02
Drugs
etripamil
03
Conditions
paroxysmal supraventricular tachycardia (PSVT)
Beyond the preview
Go deeper on NCT03464019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03464019.